19 Jun, 2013
The Leela Palace, Bengaluru
Thursday, November 8, 2012 - 18:51 IST
Sun Pharma to acquire Nasdaq-listed DUSA Pharma for $230M
BY TEAM VCC
This deal comes just three months after Sun reached an agreement to buy out the minority shareholders of NYSE-listed Taro Pharma for up to $592M.
Mumbai-based Sun Pharma Industries Ltd, India’s largest pharmaceutical company by market capitalisation, has struck another large overseas acquisition to buy NASDAQ-listed dermatology company DUSA Pharmaceuticals, Inc., for $230 million in cash.
DUSA is focused on developing and marketing...
To continue reading this article, you must be a Premium subscriber...
A Premium membership gives you:
- Access to all premium articles including exclusives, analyses & commentary.
- Access to archives of over six years.
- Exclusive interviews with top fund managers, CEOs and bankers.
JOBS
- Associate - Red Fort Capital Advisors Pvt Ltd
- The Private Equity Associate - Nereus Capital
RECENT COMMENTS
- 15 May 2013AMULYA DEonLAFARGE IS A VERY GOOD COMPANY AND GOOD NEWS FOR NEW PROJECT.
- 04 May 2013kartikonCamson Biotech is a good company. I have been tracking its performance for a long time. I was long hoping some PE...
- 04 May 2013VaradhaonSaurabh Very well said - I have always believed that investing is a very individual, lonely affair - so it is...
- 02 May 2013AnuragonPlantar technology? Interesting, never heard about this company.
UPCOMING EVENTSchinetwork